Skip to Main Content

Advertisement

Umbrella Alt Text
header search
Search
Advanced Search
Skip Nav Destination

Issues

Volume 3, Issue 10
1 October 1997
Issue Cover
All Issues
ISSN 1078-0432
EISSN 1557-3265
Issue Sections

Advances in Brief

Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: independence from COX-2 protein expression.
D J Elder; D E Halton; A Hague; C Paraskeva
View articletitled, Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: independence from COX-2 protein expression.
Open the PDF for in another window

Research Articles

p53 immunohistochemical staining predicts residual disease after chemoradiation in patients with high-risk rectal cancer.
F R Spitz; G G Giacco; K Hess; L Larry; T A Rich; N Janjan; K R Cleary; J M Skibber
View articletitled, p53 immunohistochemical staining predicts residual disease after chemoradiation in patients with high-risk rectal cancer.
Open the PDF for in another window
Differential expression of Rb2/p130 and p107 in normal human tissues and in primary lung cancer.
A Baldi; V Esposito; A De Luca; Y Fu; I Meoli; G G Giordano; M Caputi; F Baldi; A Giordano
View articletitled, Differential expression of Rb2/p130 and p107 in normal human tissues and in primary lung cancer.
Open the PDF for in another window
MYCN protein expression as a predictor of neuroblastoma prognosis.
H S Chan; B L Gallie; G DeBoer; G Haddad; N Ikegaki; J Dimitroulakos; H Yeger; V Ling
View articletitled, MYCN protein expression as a predictor of neuroblastoma prognosis.
Open the PDF for in another window
Intracellular levels of SGP-2 (Clusterin) correlate with tumor grade in prostate cancer.
J Steinberg; R Oyasu; S Lang; S Sintich; A Rademaker; C Lee; J M Kozlowski; J A Sensibar
View articletitled, Intracellular levels of SGP-2 (Clusterin) correlate with tumor grade in prostate cancer.
Open the PDF for in another window
Evaluation of continuous infusion suramin in metastatic breast cancer: impact on plasma levels of insulin-like growth factors (IGFs) and IGF-binding proteins.
J B Lawrence; C A Conover; T C Haddad; J N Ingle; J M Reid; M M Ames; V J Suman; R S Marks; C Erlichman; L C Hartmann
View articletitled, Evaluation of continuous infusion suramin in metastatic breast cancer: impact on plasma levels of insulin-like growth factors (IGFs) and IGF-binding proteins.
Open the PDF for in another window
Phase II study of recombinant interleukin 1alpha and etoposide in patients with relapsed osteosarcoma.
L L Worth; N Jaffe; R S Benjamin; N E Papadopoulos; S Patel; A K Raymond; S F Jia; C Rodriguez; J Gano; M A Gianan; E S Kleinerman
View articletitled, Phase II study of recombinant interleukin 1alpha and etoposide in patients with relapsed osteosarcoma.
Open the PDF for in another window
Intermittent exposure of medulloblastoma cells to topotecan produces growth inhibition equivalent to continuous exposure.
M K Danks; C A Pawlik; D O Whipple; J S Wolverton
View articletitled, Intermittent exposure of medulloblastoma cells to topotecan produces growth inhibition equivalent to continuous exposure.
Open the PDF for in another window
5-Fluorouracil interferes with paclitaxel cytotoxicity against human solid tumor cells.
K R Johnson; L Wang; M C Miller, 3rd; M C Willingham; W Fan
View articletitled, 5-Fluorouracil interferes with paclitaxel cytotoxicity against human solid tumor cells.
Open the PDF for in another window
Monohydroxyethylrutoside, a dose-dependent cardioprotective agent, does not affect the antitumor activity of doxorubicin.
S A van Acker; E Boven; K Kuiper; D J van den Berg; J A Grimbergen; K Kramer; A Bast; W J van der Vijgh
View articletitled, Monohydroxyethylrutoside, a dose-dependent cardioprotective agent, does not affect the antitumor activity of doxorubicin.
Open the PDF for in another window
Impact of the putative differentiating agents sodium phenylbutyrate and sodium phenylacetate on proliferation, differentiation, and apoptosis of primary neoplastic myeloid cells.
S D Gore; D Samid; L J Weng
View articletitled, Impact of the putative differentiating agents sodium phenylbutyrate and sodium phenylacetate on proliferation, differentiation, and apoptosis of primary neoplastic myeloid cells.
Open the PDF for in another window
Resistance to cytotoxic drugs in DNA mismatch repair-deficient cells.
S Aebi; D Fink; R Gordon; H K Kim; H Zheng; J L Fink; S B Howell
View articletitled, Resistance to cytotoxic drugs in DNA mismatch repair-deficient cells.
Open the PDF for in another window
Activity of temozolomide against human tumor colony-forming units.
E Raymond; E Izbicka; H Soda; S L Gerson; M Dugan; D D Von Hoff
View articletitled, Activity of temozolomide against human tumor colony-forming units.
Open the PDF for in another window
Flavonoids as enhancers of x-ray-induced cell damage in hepatoma cells.
J van Rijn; J van den Berg
View articletitled, Flavonoids as enhancers of x-ray-induced cell damage in hepatoma cells.
Open the PDF for in another window
Cyclic adenosine-3',5'-monophosphate-mediated cytotoxicity in steroid sensitive and resistant myeloma.
N L Krett; J L Zell; R G Halgren; S Pillay; A E Traynor; S T Rosen
View articletitled, Cyclic adenosine-3',5'-monophosphate-mediated cytotoxicity in steroid sensitive and resistant myeloma.
Open the PDF for in another window
Successful treatment of canine malignant histiocytosis with the human major histocompatibility complex nonrestricted cytotoxic T-cell line TALL-104.
S Visonneau; A Cesano; T Tran; K A Jeglum; D Santoli
View articletitled, Successful treatment of canine malignant histiocytosis with the human major histocompatibility complex nonrestricted cytotoxic T-cell line TALL-104.
Open the PDF for in another window
Inhibition of murine renal carcinoma pulmonary metastases by systemic administration of interferon gamma: mechanism of action and potential for combination with interleukin 4.
G G Hillman; E Younes; D Visscher; F Hamzavi; S Kim; J S Lam; E J Montecillo; E Ali; J E Pontes; R K Puri; G P Haas
View articletitled, Inhibition of murine renal carcinoma pulmonary metastases by systemic administration of interferon gamma: mechanism of action and potential for combination with interleukin 4.
Open the PDF for in another window
Angiogenesis correlates with vascular endothelial growth factor expression but not with Ki-ras oncogene activation in non-small cell lung carcinoma.
M S Tsao; N Liu; T Nicklee; F Shepherd; J Viallet
View articletitled, Angiogenesis correlates with vascular endothelial growth factor expression but not with Ki-ras oncogene activation in non-small cell lung carcinoma.
Open the PDF for in another window
Cathepsins B, H, and L and their inhibitors stefin A and cystatin C in sera of melanoma patients.
J Kos; B Stabuc; A Schweiger; M Krasovec; N Cimerman; N Kopitar-Jerala; I Vrhovec
View articletitled, Cathepsins B, H, and L and their inhibitors stefin A and cystatin C in sera of melanoma patients.
Open the PDF for in another window
Abnormal bcl-2 and pRb expression are independent correlates of radiation response in muscle-invasive bladder cancer.
A Pollack; C S Wu; B Czerniak; G K Zagars; W F Benedict; T J McDonnell
View articletitled, Abnormal bcl-2 and pRb expression are independent correlates of radiation response in muscle-invasive bladder cancer.
Open the PDF for in another window
p21 expression as a predictor for favorable prognosis in squamous cell carcinoma of the lung.
T Komiya; Y Hosono; T Hirashima; N Masuda; T Yasumitsu; K Nakagawa; M Kikui; A Ohno; M Fukuoka; I Kawase
View articletitled, p21 expression as a predictor for favorable prognosis in squamous cell carcinoma of the lung.
Open the PDF for in another window
Urokinase-type plasminogen activator in colorectal cancer: relationship with clinicopathological features and patient outcome.
M M Skelly; A Troy; M J Duffy; H E Mulcahy; C Duggan; T G Connell; D P O'Donoghue; K Sheahan
View articletitled, Urokinase-type plasminogen activator in colorectal cancer: relationship with clinicopathological features and patient outcome.
Open the PDF for in another window
Cancers of the papilla of vater: mutator phenotype is associated with good prognosis.
A Achille; M O Biasi; G Zamboni; G Bogina; C Iacono; G Talamini; G Capella; A Scarpa
View articletitled, Cancers of the papilla of vater: mutator phenotype is associated with good prognosis.
Open the PDF for in another window
Relative contribution of normal and neoplastic cells determines telomerase activity and telomere length in primary cancers of the prostate, colon, and sarcoma.
M Engelhardt; J Albanell; P Drullinsky; W Han; J Guillem; H I Scher; V Reuter; M A Moore
View articletitled, Relative contribution of normal and neoplastic cells determines telomerase activity and telomere length in primary cancers of the prostate, colon, and sarcoma.
Open the PDF for in another window
Neuron-specific hel-N1 and HuD as novel molecular markers of neuroblastoma: a correlation of HuD messenger RNA levels with favorable prognostic features.
N S Ball; P H King
View articletitled, Neuron-specific hel-N1 and HuD as novel molecular markers of neuroblastoma: a correlation of HuD messenger RNA levels with favorable prognostic features.
Open the PDF for in another window
Allelic loss on chromosome 13q in human prostate carcinoma.
J Melamed; J M Einhorn; M M Ittmann
View articletitled, Allelic loss on chromosome 13q in human prostate carcinoma.
Open the PDF for in another window
Expression of nucleolar protein p120 in human lung cancer: difference in histological types as a marker for proliferation.
B Uchiyama; Y Saijo; N Kumano; T Abe; S Fujimura; K Ohkuda; M Handa; K Satoh; T Nukiwa
View articletitled, Expression of nucleolar protein p120 in human lung cancer: difference in histological types as a marker for proliferation.
Open the PDF for in another window
Deregulated expression of p27(Kip1) in human breast cancers.
A Sgambato; Y J Zhang; N Arber; H Hibshoosh; Y Doki; M Ciaparrone; R M Santella; A Cittadini; I B Weinstein
View articletitled, Deregulated expression of p27(Kip1) in human breast cancers.
Open the PDF for in another window
Frequent alteration of CDKN2 (p16(INK4A)/MTS1) expression in human primary prostate carcinomas.
S G Chi; R W deVere White; J T Muenzer; P H Gumerlock
View articletitled, Frequent alteration of CDKN2 (p16(INK4A)/MTS1) expression in human primary prostate carcinomas.
Open the PDF for in another window

Advertisement

Breaking
Some Acne Creams Found to Contain Known Carcinogen
Breast Cancer Incidence Up by Half in AAPI Women
Genentech Buys Regor’s CDK Inhibitors for $850 Million
View more recent articles
Latest News
MicroRNAs, Focus of Nobel Prize, Highlight Untapped Potential
COVID-19 Vaccines Linked to Improved Survival in ICI-Treated Cancers
Immigration Systems Hampering Global Research
View more recent articles
Research Watch
Patient Response to Immunotherapy Is Dictated by Five Latent Factors
Type 2 Immune Factors Enhance T Cell–Driven Antitumor Immune Responses
Pan-KRAS Degraders Effectively Target KRAS-Mutant Cancers
View more recent articles

NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.

  • Online ISSN 1557-3265
  • Print ISSN 1078-0432

AACR Journals

 

 

  • Copyright © 2023 by the American Association for Cancer Research.
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept